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Abstract
Background: Breast cancer is the most common form of malignancy affecting women worldwide. It is also the
leading cancer in females in Cyprus, with approximately 400 new cases diagnosed annually. It is well recognized
that genetic variation as well as environmental factors modulate breast cancer risk. The main aim of this study was
to assess the strength of associations between recognized risk factors and breast cancer among Cypriot women.
This is the first epidemiological investigation on risk factors of breast cancer among the Cypriot female population.
Methods: We carried out a case-control study, involving 1,109 breast cancer patients and a group of 1,177 controls
who were recruited while participating in the National screening programme for breast cancer. Information on
demographic characteristics and potential risk factors were collected from both groups during a standardized
interview. Logistic regression analysis was used to assess the strength of the association between each risk factor
and breast cancer risk, before and after adjusting for the possible confounding effect of other factors.
Results: In multivariable models, family history of breast cancer (OR 1.64, 95% CI 1.23, 2.19) was the strongest
predictor of breast cancer risk in the Cypriot population. Late menarche (OR 0.64, 95% CI 0.45, 0.92 among women
reaching menarche after the age of 15 vs. before the age of 12) and breastfeeding (OR 0.74, 95% CI 0.59, 0.92)
exhibited a strong protective effect. In the case of breastfeeding, the observed effect appeared stronger than the
effect of pregnancy alone. Surprisingly, we also observed an inverse association between hormone replacement
therapy (HRT) although this may be a product of the retrospective nature of this study.
Conclusion: Overall the findings of our study corroborate with the results of previous investigations on descriptive
epidemiology of risk factors for breast cancer. This investigation provides important background information for
designing detailed studies that aim to improve our understanding of the epidemiology of breast cancer in the
Cypriot population, including the study of gene-environment interactions. Furthermore, our study provides the first
scientific evidence for formulating targeted campaigns for prevention and early diagnosis of breast cancer in
Cyprus.
Background
Breast cancer is the most frequent malignancy in the
female population of Europe and North America where
an estimated 1 in 9 women are at risk of developing the
disease [1]. Numerous epidemiological studies over the
last three decades have revealed a number of risk factors
associated with breast cancer [2-4]. In addition to
genetic and reproductive factors, breast cancer risk
displays wide ethnic and geographic variation [5].
Within Europe the incidence varies by almost two-fold.
It is highest in Northern European countries, with an
estimated 84.6 cases per 100,000 population with inter-
mediate rates recorded in Southern Europe and lowest
rates occurring in Eastern Europe with 42.6 cases per
100,000 population [6]. In addition to the geographic
variation, influences on incidence rates, have also been
attributed to differences in the use of mammography,
diet, physical activity, body size, alcohol consumption
and socioeconomic and reproductive factors [7]. The
discovery of highly penetrant breast cancer susceptibility
g e n e ss u c ha st h eBRCA genes in the mid 1990’s [8,9]
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currently believed that environmental factors are of
greater significance [10].
Cyprus is the third largest island in the Mediterranean
Sea with a Greek-Cypriot population of 749,200 as
recorded in July 2004, by the statistical service of the
Republic of Cyprus. Data from the National Cancer Reg-
istry established in 1998 by the Ministry of Health show
an average incidence of 400 female breast cancer cases
per year [11]. This corresponds to an age-standardized
incidence rate of breast cancer of 60 per 100,000 popu-
lation [11] which is comparable to the rates seen in
other Southern European countries, a region where a
moderate breast cancer risk is usually recorded [6].
Cyprus is a member of the European Union since 2004,
and has a long history of practicing a Mediterranean
lifestyle. However the lifestyle is rapidly changing
towards a western type of life, so it is of interest
to study the pattern as well as the influence of breast
cancer risk factors in our population.
Indeed, there are no data as yet available about breast
cancer risk factors in the Cypriot female population.
The main aims of this report are (a) to describe the
background levels of established and recognized breast
cancer risk factors among Cypriot women and (b) to
assess the strength of their association with breast can-
cer risk. In order to achieve this we carried out a case-
control study, involving a breast cancer patient group
and a control group of healthy Cypriot women attending
mammography clinics as part of the National screening
programme. A number of risk factors that modulate
breast cancer such as socioeconomic status, reproduc-
tive events, family history and lifestyle factors were
investigated.
Interestingly, previous published work by our group
has shown that the Cypriot population exhibits some
unique genetic features as revealed by the identification
of novel mutations in the BRCA1 and BRCA2 genes
[12,13]. Moreover, this is the first study into breast can-
cer epidemiology among the Cypriot female population
and will function as a baseline, of future efforts into
combining person-based data, with the molecular/
genetic data in order to study gene-environment interac-
tions in our population.
Methods
Study participants and data collection
The sample size was determined using power calcula-
tions in order to ensure at least 90% power to detect a
magnitude of association at the odds ratio scale of 1.5 at
5% statistical significance for an exposure that occurs
among 10% of the controls. The cases consisted of 1109
women, between 40-70 years of age who had a histologi-
cally confirmed diagnosis of primary breast cancer
between January 1999 and December of 2005. Younger
cases were excluded since in addition to the fact that
early-onset breast cancer may share a different aetiology,
the source of the controls (i.e. mammography screening
users) only effectively covers women in this age range.
During the study period (January 2004 - December
2006), breast cancer cases that fulfilled the above criteria
were approached while waiting for their oncologist
appointment and were given an introductory letter out-
lining the goals of the study. Those who agreed to parti-
cipate in the study subsequently underwent a personal
interview with a trained interviewer. The majority of
cases were ascertained from the Bank of Cyprus Oncol-
ogy Centre, which operates as a referral centre and
offers treatment and follow-up for up to 90% of all
breast cancer cases diagnosed in Cyprus. The rest of the
patients, were recruited at the Oncology Departments of
the Nicosia, Limassol, Larnaca and Paphos district
hospitals.
The control group consisted of 1177 Cypriot women
from the general population, who were invited to parti-
cipate in the National programme for breast cancer
screening with the use of mammography and received a
negative result. Volunteers were enrolled in the study
during the same calendar period as the cases, from the
5-district mammography screening centers that operate
in Cyprus. Due to the narrow age span of women
invited for screening (ages 50-69) younger and older
women were underrepresented. Nevertheless, between
the ages of 50-65, the observed age distribution roughly
matched the age structure of the island’s female popula-
tion. Women were approached while waiting for their
mammography appointment and were given an intro-
ductory letter outlining the goals of the study. Those
who agreed to participate in the study subsequently
underwent a personal interview with a well trained
interviewer.
Demographic and risk factor data were collected from
both cases and controls with the use of a specially
designed questionnaire, through a standardized inter-
view. The questionnaire used in the present study was
primarily based on a similar questionnaire used in the
East Anglia breast cancer study [14]. The study was
approved by the Cyprus National Bioethics Committee.
Each participant gave written consent and the data were
anonymised and coded into an MS ACCESS database.
The questionnaire included information on age, marital
status, level of education, current BMI, exercise status,
smoking status (i.e. never, past, current smokers), family
history of breast cancer (i.e. first degree relatives), use of
hormone replacement therapy and a range of reproduc-
tive characteristics such as age at menarche, any preg-
nancy, gestation period, parity, overall duration of
breastfeeding, use of oral contraceptives, age at first and
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than BMI (which was based on actual measurements of
weight and height), all other factors investigated here,
were self-reported. Only pregnancies with a gestation
period of at least 24 weeks were considered (including
those not resulting in a live birth). Only use of oral con-
traceptives or HRT for at least a period of 1 month was
considered. Exercise was taken to mean any activity
involving a minimum of 30 minutes walk, or other form
of regular exercise including cycling, swimming, jogging,
etc at least 3 times a week for the past 6 months. Type
of occupation was not taken into account as a form of
exercise.
Data Analysis
We computed frequencies of categorical variables (or
means and standard errors in the case of continuous
variables such as age) separately for cases and controls.
The frequencies were cross-tabulated and differences in
participant characteristics between cases and controls
were statistically assessed using the c
2 test. The strength
of association between each factor and breast cancer
risk was estimated by odds ratios (ORs), calculated
using logistic regression before and after adjusting for
the confounding effect of all other risk factors, in multi-
variable models. In the case of ordered categorical vari-
ables (e.g. age at menarche), p-value for linear trend was
reported. Due to the narrow age span of women invited
for screening (ages between 50 and 69), women younger
than 45 or older than 65 were under-represented in the
study. To control for age differences between cases and
controls, all model estimates (including associations
with single risk factors) were therefore adjusted for age.
Furthermore, the effect of restricting the investigation to
women between 45-64 years of age was also tested in
sensitivity analyses. In all cases, the fit of the models
was assessed on the basis of the Pearson c
2 and/or Hos-
mer-Lemeshow goodness-of fit statistics (which compare
the observed against the expected counts as estimated
by the model) producing a non-significant result.
A number of characteristics investigated here are (a)
dependent on each other such as pregnancy and breast-
feeding, or (b) are nested in each other such as breast-
feeding status vs. breastfeeding duration or (c) are
expected to display a high degree of collinearity i.e. num-
ber of children and breastfeeding. The inter-relationships
between these variables and the extent to which they are
independently associated with breast cancer risk was
firstly assessed in separate analyses (using stratification
techniques or multivariable logistic models as appropri-
ate), with the aim of identifying appropriate course of
action e.g. include the variable with the strongest effect
in order to avoid multicollinearity in the final model. For
instance, the possible protective effect of pregnancy and
the added effect of breastfeeding over the effect of preg-
nancy was investigated in a logistic regression model that
included the main effect of pregnancy and an interaction
term between pregnancy and breastfeeding (to capture
the combined effect of the two variables) but no separate
main effect for breastfeeding (since only women who
have had a child breastfed). Similarly, as women with
more children may be more likely to breastfeed (and in
fact breastfeed for longer), we assessed the extent to
which breastfeeding confounds or modifies any observed
association between breast cancer risk and number of
children by calculating Mantel-Haenszel odds ratios after
stratifying by breastfeeding status along with a c
2 test
of heterogeneity of estimates. All data manipulation and
statistical analyses were performed in STATA SE 9.0.
Results
A total of 2286 women - 1109 breast cancer cases and
1177 healthy controls (98% and 98% participation rate
respectively) - from all five districts of Cyprus partici-
pated in the study. The mean ± SD age of cases and
controls were 56.1 ± 9.1 and 55.7 ± 7.0 years respec-
tively (p-value of t-test for difference in means = 0.22).
Nevertheless, differences in the age distribution of cases
and controls recruited into the study were observed
mainly due to the under-representation of younger and
older age-groups amongst the controls. Table 1 presents
the distribution of socio-economic characteristics and
potential risk factors investigated among cases and con-
trols separately. One in four Cypriot women have never
breast-fed, as many as 80% have had at least two chil-
dren and more than 70% reported having never used
hormone replacement therapy. No statistically signifi-
cant differences between cases and controls were
observed in terms of level of education, marital status,
number of children or use of oral contraceptives. In
contrast, a higher proportion of cases than controls
reported family history of breast cancer (14.1% vs. 9.1%)
and early menarche (14.2% vs. 11.4%).
Some strong associations were observed between the
reproductive factors investigated and breast cancer risk.
In general, cases were less likely than controls to have
been pregnant (OR 0.69, 95%CI 0.49-0.97) or to have
breastfed (OR 0.69, 95%CI 0.57-0.82). These variables
are expected to exhibit a high degree of collinearity.
Table 2 investigates the synergistic role of (a) breast-
feeding and pregnancy as well as (b) breastfeeding and
number of children in breast cancer risk. The combined
effect of breastfeeding and pregnancy appeared stronger
than the effect of pregnancy alone; the association with
the latter attenuated after accounting for breastfeeding.
Interestingly, no stepwise relationship was observed
between breast cancer risk and reported duration of
breastfeeding. In fact, risk of breast cancer appeared
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while estimated odds ratios were of similar magnitude.
The Likelihood Ratio Test comparing the goodness of
fit of the model with ordered categories vs. the simpler
model where breastfeeding was expressed as a binary
variable produced p-values of 0.27 in the unadjusted,
0.19 and 0.33 in the adjusted models respectively, sug-
gesting no evidence of an improved fit of the full model.
Further adjusting for all other variables did not alter our
inferences.
A strong inverse association was observed between
breast cancer risk and number of children. Compared
to nulliparous women, crude odds ratios were 0.90,
0.84 and 0.68 in women with one, two and three chil-
dren respectively; p-value for trend < 0.01. However, as
expected, there was a strong association between num-
ber of children and likelihood of breastfeeding. Nearly
half of women with one child reported not having
Table 1 Socio-demographic characteristics and potential
risk factors among participants
Characteristic Cases
(N = 1109)
Controls
(N = 1177)
N% N% p -
value
1
Age
<45 121 10.9 68 5.8
45-54 354 31.9 440 37.4
55-64 394 35.5 526 44.7
≥65 240 21.6 140 11.9
Not reported 0 0.0 3 0.3 <0.01
2
Mean (SD) 56.1
(9.1)
55.7
(7.0)
0.22
3
Education
Primary 418 37.7 464 39.4
Secondary 412 37.2 435 37.0
Tertiary 131 11.8 147 12.5
University 135 12.2 122 10.4
Not reported 13 1.2 9 0.8 0.51
Marital status
Married 921 83.1 1015 86.2
Widowed/Divorced 130 11.7 117 9.9
Single 57 5.1 42 3.6
Not reported 1 0.1 3 0.3 0.09
BMI
<18.5 13 1.2 11 0.9
18.5-24.5 314 28.3 322 27.4
25-29.5 368 33.2 463 39.3
≥30 337 30.4 269 22.9
Not reported 77 6.9 112 9.5 <0.001
Family history of breast
cancer
No 953 85.9 1068 90.7
Yes 156 14.1 107 9.1
Not reported 0 0.0 2 0.2 <0.001
Age at menarche
≤11 years 157 14.2 134 11.4
12-14 years 798 72.0 838 71.2
≥15 years 154 13.9 205 17.4 0.02
Pregnancy
4
Yes 1021 92.1 1110 94.3
No 88 7.9 67 5.7 0.03
Number of children
4
None 103 9.3 88 7.5
One 90 8.1 82 7.0
Two 480 43.3 492 41.8
Three or more 436 39.3 515 43.8 0.10
Age at 1st pregnancy
5
<30 851 83.4 971 87.5
≥30 140 13.7 116 10.5
Not reported 30 2.9 23 2.1 0.03
Table 1 Socio-demographic characteristics and potential
risk factors among participants (Continued)
Breastfeeding
5
Never 305 29.9 279 25.1
≤6 months 329 32.2 385 34.7
7-12 months 166 16.3 181 16.3
More than 1 year 221 21.7 265 23.9 0.09
Oral contraceptive use
No 823 74.2 879 74.7
Yes 280 25.3 294 25.0
Not reported 6 0.5 4 0.3 0.76
HRT use
Never 937 84.5 838 71.2
<6 months 41 3.7 64 5.4
6-60 months 86 7.8 182 15.5
≥60 months 45 4.1 92 7.8
Not reported 0 0.0 1 0.1 <0.001
Smoking
Never 869 78.4 955 81.1
Past 130 11.7 76 6.5
Current 108 9.7 143 12.2
Not reported 2 0.2 3 0.3 <0.001
Exercise
6
Yes 544 49.1 635 54.0
No 563 50.8 539 45.8
Not reported 2 0.2 3 0.3 0.06
Notes:
1P-value of c
2 test for independence.
2Differences in the age
distribution among cases and controls are mainly driven by the under-
representation of controls in the younger and older age-groups. After
restricting to ages 45-65, p-value becomes 0.46.
3P-value of t-test for
difference in mean age between cases and controls.
4The difference in
number of women reporting not having had a pregnancy (N = 155) and not
having had a child (N = 191) is due to the fact that 15 and 21 women in
cases and controls respectively have reported been pregnant not resulting in
birth.
5Restricted to those women who have had a pregnancy.
6Only
information on current exercise status was available.
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longer than 6 months. In contrast, amongst women
with 3 or more children, only 15% did not breastfeed
while as many as 38% reported breastfeeding for at
least one year. The Kendall’st a u - bw a s0 . 4 2 ,p - v a l u e
for independence < 0.001, indicating a relatively strong
and statistically significant correlation between breast-
feeding duration and number of children. Considering
every possible pair among the participants, this non-
parametric measure is calculated on the basis of the
number of occasions where the ranking of both breast-
feeding duration and number of children are in the
expected direction (i.e. a higher rank in one variable is
accompanied by a higher rank in the other) as com-
pared to the number of discordant pairs. The strong
univariable association observed with number of chil-
dren attenuated once breastfeeding was controlled for
in the multivariable logistic analysis while not much
change was observed in the case of breastfeeding. This
cannot be simply a result of collinearity as the confi-
dence intervals also remained largely unaffected, more
likely indicating that the observed association with
number of children was confounded by the effect of
breastfeeding.
In fact, this is also supported from the results of the
stratified analysis where the estimate for the odds ratio
for a one unit increase in the number of children was
0.92 (95%CI 0.80-1.05) among women who did not
breastfeed and 0.97 (95%CI 0.82-1.15) among women
who breastfed. The Mantel-Haenszel estimate control-
ling for breastfeeding is 0.94 (95% CI 0.85, 1.04) and
test of homogeneity of ORs = 0.61, indicating no evi-
dence of effect modification in the relationship of breast
cancer and number of children by breastfeeding status.
Further adjusting for other variables revealed no associa-
tion with parity while interestingly wide confidence
intervals were observed. On the other hand, the effect
estimate of breastfeeding (and the confidence intervals
for that matter) practically remained unchanged at 0.72
(95%CI 0.58, 0.90).
Table 3 presents odds ratios (and 95% CI) for breast
cancer in terms of each participant characteristic before
and after adjusting for the effect of all other in a multi-
variable model. On the basis of the results presented
above, breastfeeding was included as a binary variable
while parity was not considered further in the multivari-
able models. The strongest associations were observed
with family history of breast cancer, age at menarche
Table 2 Odds Ratios of breast cancer risk in terms of A) pregnancy and breastfeeding (either status or duration) and
B) breastfeeding and number of children before and after adjusting for the effect of each other and all other risk
factors in multivariable logistic models
Before adjustment After mutual adjustment Fully adjusted
4
OR (95%CI) p-value OR (95%CI) p-value OR (95%CI) p-value
A. Pregnancy
No 1.00
Yes 0.69 (0.49,0.97) 0.03 0.89 (0.62,1.28) 0.54 1.07 (0.66,1.72) 0.79
Breastfeeding
1
No 1.00
Yes 0.69 (0.57,0.82) <0.001 0.63 (0.45,0.89) <0.01 0.72 (0.59,0.90) <0.01
Breastfeeding by duration
1, 2
Never 1.00
≤6 months 0.71 (0.58,0.88) 0.65 (0.45,0.94) 0.73 (0.57,0.93)
7-12 months 0.76 (0.58,0.98) 0.69 (0.47, 1.03) 0.86 (0.64,1.16)
>1 year 0.61 (0.48,0.77) <0.001
3 0.56 (0.38,0.81) <0.001
3 0.68 (0.51,0.91) 0.04
3
B. Breastfeeding
No 1.00
Yes 0.69 (0.57,0.83) 0.03 0.72 (0.58,0.88) <0.01 0.72 (0.58,0.90) <0.01
Number of children
None 1.00
One 0.90 (0.59,1.37) 1.06 (0.69,1.64) 1.29 (0.76,2.18)
Two 0.84 (0.61,1.15) 1.04 (0.74,1.48) 1.27 (0.76,2.18)
Three 0.68 (0.49,0.94) <0.01
3 0.90 (0.62,1.29) 0.25
3 1.14 (0.82,1.99) 0.87
Notes:
1In the adjusted models, odds ratio refers to the combined effect of pregnancy and breastfeeding, status or duration respectively, as estimated in a model
with an interaction term between the two variables but no main effect for breastfeeding.
2p-values of Likelihood Ratio Test comparing the goodness of fit of
model including breastfeeding duration Vs simpler model with breastfeeding expressed as binary variable = 0.27, 0.19 and 0.33 respectively, indicating no better
fit of full model.
3P-value for trend across ordered categories.
4Due to collinearity, the variables pregnancy and number of children were mutually excluded from
the fully adjusted models.
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after adjusting for the effect of all other factors. For
instance, the adjusted odds ratio for family history was
1.64 (95% CI 1.23-2.19) while for breastfeeding this fig-
ure was 0.74 (95% CI 0.59-0.92). Finally, a statistically
significant trend with age at menarche and breast cancer
risk was also observed. Women who started menstruat-
ing earlier than the age of 11 had an increased risk for
breast cancer compared to women who started menstru-
ating later, even after adjusting for the effect of all other
risk factors. Adjusted odds ratio in women who started
menstruating between the ages 12-14 was 0.82 (95%CI
0.62-1.10) and 0.64 (95%CI 0.45-0.82) in those who
started after the age of 15 years; p-value for linear trend
< 0.01.
None or only weak associations were observed
between breast cancer risk and other risk factors investi-
gated, for instance BMI, age at first pregnancy, smoking,
exercise or use of oral contraceptives. Surprisingly, more
controls (28.8%) than cases (15.5%) reported taking hor-
mone replacement therapy (HRT). The inverse associa-
tion persisted in the fully adjusted model, and in fact
Table 3 Odds ratios (95% CI) of breast cancer by participants characteristics before and after adjusting for the effect
of all other in a multivariable model
Risk factor Univariable
1 Multivariable (N = 2020)
2, 6
OR (95%CI) p-value
3 OR (95% CI) p-value
3
Education Primary 1.00
Secondary 1.17 (0.96,1.45) 1.18 (0.94,1.48)
Tertiary 1.09 (0.81,1.45) 1.12 (0.81,1.53)
University 1.35 (1.00,1.82) 0.07 1.40 (1.00,1,95) 0.08
Marital status Married 1.00
Widowed/Divorced 1.08 (0.82,1.42) 0.57 1.06 (0.78,1.44) 0.84
Single 1.55 (1.02,2.34) 0.04 1.28 (0.69,2.35) 0.43
BMI <25 1.00
25-30 0.80 (0.64,0.98) 0.86 (0.69,1.07)
≥30 1.21 (0.96,1.53) 0.11* 1.22 (0.95,1.56) 0.14*
Family history of breast cancer No 1.00
Yes 1.68 (1.29,2.19) <0.001 1.64 (1.23,2.19) 0.001
Age at menarche (years) ≤11 1.00
12-14 0.80 (0.62,1.03) 0.82 (0.62,1.10)
≥15 0.61 (0.44,0.84) <0.01 0.64 (0.45,0.92) 0.01
Age at 1st pregnancy (years) <30 1.00
≥30 1.36 (1.04,1.77) 1.25 (0.93,1.68) 0.14
Never
4 1.51 (1.08,2.12) <0.01 0.93 (0.57,1.54) 0.76
Breastfeeding
5 No 1.00
Yes 0.63 (0.45,0.89) <0.01 0.74 (0.59,0.92) 0.01
Oral contraceptive use No 1.00
Yes 1.03 (0.86,1.26) 0.70 1.02 (0.83,1.27) 0.84
HRT use (months) Never 1.00
<6 0.63 (0.42,0.95) 0.67 (0.42,1.05)
6-60 0.49 (0.37,0.65) 0.47 (0.35,0.64)
≥60 0.50 (0.34,0.72) <0.001 0.53 (0.35,0.79) <0.001
Exercise No 1.00
Yes 0.86 (0.72,1.01) 0.07 0.94 (0.78, 1.13) 0.48
Smoking Never 1.00
Past/Current 1.24 (1.01,1.53) 0.05 1.16 (0.91,1.47) 0.23
Notes:
1In all cases, models were adjusted for age. Both univariable and multivariable inferences remain largely unaffected when restricting the analyses to ages
45-64.
2Further adjusting for the effect of all other risk factors considered here.
3P-value for difference between levels of binary/nominal variables (e.g. family
history) or p-value for linear trend across ordinal categorical variables (e.g. age at menarche or age at 1
st pregnancy).
4The variable ‘pregnancy’ was not included
in the multivariable model as its effect is captured accordingly by category ‘never’ of the variable “age at 1
st pregnancy”.
5Odds ratio of the combined effect of
breastfeeding after adjusting for pregnancy in a logistic model with an interaction term between the two variables but no main effect for breastfeeding.
6The
p-value of the Pearson c
2 goodness-of-fit test was 0.18 in the case of the full model and 0.55 for the model where only statistically significant variables were
included (i.e. family history, breastfeeding, age at menarche and HRT use), in both cases suggesting a reasonable fit of the model *Evidence of non-linearity
based on Likelihood Ratio Test comparing the goodness of fit of model with ordered categories Vs linear term across categories.
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the duration of HRT use. Adjusting for number of chil-
dren in the multivariable models, did not affect any of
the estimates. Indicatively, the odds ratio for family his-
tory now becomes 1.62 (95%CI 1.22, 2.16), while the
estimates were 0.83 (95% 0.62, 1.09) and 0.67 (95% 0.47,
0.94) in women who reached menarche between the
ages of 12-14 and 15 or later respectively. Lastly, infer-
ences were also unaffected when breastfeeding was
expressed in terms of duration in the multivariable
models (instead of the binary classification presented in
the table).
Discussion
The aetiology of breast cancer is still poorly understood
and known breast cancer risk factors explain only a
small proportion of cases. Epidemiological studies con-
ducted in different populations have identified a spec-
trum of well established and probable risk factors for
breast cancer [15]. These include age, socioeconomic
status, reproductive events, breastfeeding, family history
and lifestyle among others. However, most epidemiolo-
gical breast cancer studies involve subjects living in
North America and Western Europe, regions which
represent only a fraction of the global population.
Therefore there is a need to study breast cancer epide-
miology in populations in less-well studied regions of
the world, in order to gain a better understanding of
breast cancer aetiology [15]. It is noted that this is the
first epidemiological study into breast cancer risk factors
in the Cypriot population.
The main aim of this study was to assess the strength
of associations between some recognized risk factors
and breast cancer among Cypriot women. We should
note that while the factors investigated here (other than
BMI) were all self-reported, there is no reason to believe
that any recall should be substantially differential, not
least due to the standardised interview procedure by
which information was collected from both groups of
participants. A total of 1109 Cypriot women diagnosed
with breast cancer between years 1999-2005 were
recruited. It should be noted that the incidence of breast
cancer in Cyprus is now around 400 cases per year. The
cases in this study represents as many as 50% of the
total number of cases diagnosed between 1999-2005. As
many as 90% of all breast cancer cases in Cyprus are
registered, receive treatment and are followed by the
Bank of Cyprus Oncology Centre in Nicosia. This cen-
tralized point of access, ensures that the study partici-
pants, are to a large extent representative of all cases on
the island, in terms of their socio-demographic charac-
teristics. It should be noted that the recruitment of
cases was based on the list of scheduled appointments
during the study period and not on a random selection
of all diagnosed cases.
The 1177 controls were recruited amongst women
who participated in the National breast cancer screening
programme with the use of mammography, to a large
extent the same population that would give rise to the
cases. Since no matching was employed, unavoidable
(small) differences in the age distribution between the
cases and the controls (mainly due to the under-repre-
sentation of younger and older age-groups amongst the
mammography screening users) were dealt with by
adjusting for age in multivariable analyses. The Cypriot
National screening programme for breast cancer in all
women aged 50-69 was officially introduced in 2006,
after being pilot tested at a small-scale in 2003. Recent
data from the Cyprus Ministry of Health suggest that
more than half of the women invited respond to the
call. Even so this does not imply that the sample of con-
trols are representative of the general female population
on the island, in terms of the background socio-eco-
nomic characteristics and levels of potential risk factors
for breast cancer in the general population.
In terms of the basic demographic characteristics of
the two groups, no major differences were detected in
the levels of education or marital status. However, well
established risk factors for breast cancer identified in
other populations, such as family history of breast can-
cer, age at menarche and breastfeeding exhibited the
strongest associations with breast cancer risk among
Cypriot women [4,5,10]. Unlike Britain and other Eur-
opean countries, there are no formal occupation-based
socio-economic classification systems in Cyprus. In the
absence of such socio-economic indicators or informa-
tion on family income, educational status was used as a
proxy. Controlling for the possible confounding effect of
educational status in multivariable models did not affect
inferences about major risk factors of breast cancer.
Healthy volunteers who participate in epidemiological
studies tend to have a higher educational level, com-
pared to the rest of the population [16]. In general, no
major differences in the level of education between
cases and controls were observed in this study. Never-
theless, it is possible that women who attend the screen-
ing programme are likely to be more educated, thus
masking any such differences. Furthermore, a study of
risk factors of breast cancer in Iran has shown that mar-
ital status may have an impact on the incidence of
breast cancer in Iranian women. It was observed that
women who never married were at higher risk for breast
cancer [17]. However, marital status by itself may not be
a determining factor for modifying breast cancer risk.
Since there is a strong interaction between marital sta-
tus and parity, the increased breast cancer risk
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nulliparity.
Many studies have examined the association between
body mass index (BMI) and breast cancer incidence. It
was observed that in postmenopausal women, obesity
(BMI > 30 kg/m
2) was associated with about 50%
increase in breast cancer risk when compared with lean
women (BMI 20 kg/m
2). This association was not
observed in premenopausal women. In contrast, in some
studies it was observed that during the premenopausal
years, breast cancer risk was slightly lower in obese
women [18]. In our study, no information on meno-
pause status at the time of diagnosis was available. By
comparing BMI at the time of interview between cases
and controls, no statistically significant differences were
observed between the two groups. The relationship
between BMI and breast cancer risk is complex and is
better assessed in prospective studies where further
anthropometric data are accurately collected at baseline
and at regular intervals afterwards. In this context, no
conclusive results regarding the association between
BMI and breast cancer incidence in the Cypriot popula-
tion can be drawn on the basis of this study.
Family history of breast cancer is one of the most well
established, widely accepted risk factors for this disease.
Having one first-degree relative with breast cancer
approximately doubles a woman’s risk for developing
breast cancer. The risk is elevated significantly by
increasing the number of affected relatives [19,20]. Our
findings are in accordance with other published studies
and suggest that a positive family history of breast can-
cer is one of the most significant risk factors for this
disease in Cyprus. In fact, if women with positive family
history of cancer are more likely to attend mammogra-
phy clinics for screening, the observed association may
actually be an underestimation.
Breast cancer risk is associated with several reproduc-
tive factors. It is well established that breast cancer risk
increases with early age at menarche [21-23]. This asso-
ciation is consistent with the hypothesis that breast can-
cer risk is related to the extent of breast mitotic activity.
This activity is driven by estrogen and progesterone
exposure during the luteal phase of the menstrual cycle
[24], which determines the probability of tumorigenic
somatic events [25]. Therefore, an early age at menarche
increases the period during which the breast is mitoti-
cally active and subsequently increases breast cancer
risk. Similarly to previous investigators, we observed
that an early age at menarche is associated with an ele-
vated risk of breast cancer in our population.
The effect of breastfeeding on breast cancer risk has
been controversial indicating either no association, or a
weak protective effect against breast cancer [26]. Studies
in countries with a long duration of breastfeeding have
reported substantial protective effects, whereas a num-
ber of studies in Western populations failed to detect an
association, possibly due to the low prevalence of pro-
longed breastfeeding [26]. A meta-analysis of breastfeed-
ing and breast cancer risk, by the Collaborative Group
on Hormonal Factors in Breast Cancer, showed that
increasing duration of breastfeeding confers a protective
effect on breast cancer risk, over and above that already
known to be afforded by parity itself [27]. Breastfeeding
is hypothesized to reduce the risk of breast cancer pri-
marily through two mechanisms, differentiation of
breast tissue [28] and reduction of the lifetime number
of ovulatory cycles [29]. The results of our study suggest
an inverse association between breastfeeding and breast
cancer risk, even though a dose-response relationship
with self-reported duration of breastfeeding was not
observed, possibly a result of misclassification. This find-
ing is consistent with the results of the large collabora-
tive study showing breastfeeding to be protective for
breast cancer [27]. Breastfeeding is one of the few
potentially modifiable factors that can reduce breast
cancer risk. Further investigations are warranted in
order to understand the underlying mechanisms of the
protective effect of breastfeeding and how protection
might be conferred. Once these are determined, inter-
ventions, which would mimic breastfeeding, could be
developed for the benefit of women who have never
breastfed [27].
Surprisingly, we observed an inverse association
between hormone replacement therapy (HRT) and
breast cancer risk. Results from randomized controlled
trials and from observational studies have shown that
use of HRT increases breast cancer risk. Furthermore,
the effect of HRT on breast cancer risk depends also on
the different combinations of HRT as well as on the
duration of usage [30-34]. Overall, studies have con-
cluded that oestrogen-progestagen combinations
increase the risk of breast cancer, and that the risk was
elevated, in women who were treated for at least 5 years
[32,34]. The above results should be interpreted with
caution due to the difficulties experienced by Cypriot
women in recalling information regarding type and
exact duration of HRT use. However, there is no reason
to believe that such recall was differential among cases
and controls. Unlike other studies [34,35], the vast
majority of women in our sample reported never having
used HRT while only a small percentage of women in
our sample reported use for periods longer than 5 years
(e.g. 7.8% among healthy controls). Furthermore, while
in prospective studies one would expect to find an asso-
ciation between HRT use and breast cancer risk, in our
retrospective study it is not surprising to observe an
inverse association. It is very likely though that cases,
once diagnosed with breast cancer, were not prescribed
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seen in our study.
Only a weak association was observed between life-
style risk factors such as exercise and smoking. It should
be noted though that these parameters refer to current
status only, as no information for past habits, duration
or intensity of smoking were available. As a result, any
association is hard to interpret due to problems with
directionality of effect e.g. associations with exercise
may be more likely to reflect that women diagnosed
with breast cancer are less likely to currently exercise,
rather than a causal relationship between lack of exer-
cise and breast cancer.
Conclusions
The strongest associations with breast cancer risk in the
Cypriot population were observed with family history of
breast cancer, early menarche and breastfeeding. It is
noteworthy that the protective effect of breastfeeding
appeared stronger than the effect of pregnancy alone.
Overall, the findings of our study corroborate with the
results of previous investigations on descriptive epide-
miology of risk factors for breast cancer. Nevertheless,
this study presents the first report for breast cancer risk
factors in Cypriot women and provides the first scienti-
fic evidence using National data, for executing more tar-
geted campaigns of prevention and early diagnosis in
the Cypriot population.
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